Headache Research Library

Brian Plato, DO, FAHS, is the medical director of headache medicine at Norton Neuroscience Institute in Louisville, Kentucky. He recently discussed red flags in headache history...

The impact of migraine treatment not associated with pregnancy complications, but further research needed, expert says

Three observational studies to be presented at the American Headache Society (AHS) 61st Annual Scientific Meeting in Philadelphia, July 11-14, provide insight into how opioids are being used to treat migraine in a range of acute care settings.

At the American Headache Society (AHS) 61st Annual Scientific Meeting, researchers are presenting data looking at the impact of mindfulness-based cognitive therapy (MBCT) on migraine-related disability.

Andrew Hershey, MD, PhD, FAHS, walks through the characteristics of headache and how to classify them

This non-invasive, FDA-cleared treatment option decreases the likelihood of headaches

Dr. Tepper walks through what needs to be considered when determining how to treat a patient’s migraine attacks

Insights on building the strongest connection possible between neurologists and patients with migraine

The National Institute of Neurological Disorders and Stroke is funding research in clinical trial networks which will support headache and migraine research. In addition...

Umer Najib, MD, FAHS, shares who is a suitable candidate for non-invasive neuromodulation and explains how to gauge treatment success

President of the Canadian Headache Society, neurologist and migraine advocate Dr. Leroux discusses migraine stigma and access to care.

Poor sleep habits and migraine continue to be linked as more advanced technology allows physicians to reveal a stronger connection.

Mitochondrial disease presents in many forms with varying symptoms, ranging from developmental delays to neurological issues, including frequent headaches. Until recently, it has been unclear whether the headaches patients with mitochondrial disease experience are caused by a primary or secondary disorder.

There is a higher prevalence of migraine among women, compared with men, so it’s important to consider risks as they relate to women’s health issues—namely when prescribing oral contraceptives.